Issue 03 - The Cancer Letter

Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.

SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.

LOGIN SUBSCRIBE NOW

SEARCH DATE

SEARCH TEXT

Cancel

OK

Cancel

OK

Delete Account

Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below

CMS Opens Door to Coverage of Comprehensive Genomic Sequencing

Duke's Legal Stance: We Did No Harm

Misconduct Expert Dissects Duke Scandal

Cancer Drug Prices Increased $8,500 Per Year Since 1995

President Obama Launches Precision Medicine Initiative

ASCO Teams with SAP For CancerLinQ Project

Is $100M in Stock Enough to Make MD Anderson Go Public with its Conflict-of-Interest Management Plan?

LLS President Responds To "Bad Luck" Cancer Study

In Brief

Lancaster Leaves Moffitt To Join Myriad Genetics

Sue Biggins receives prize from Genetics Society of America

Pancreatic Cancer Action Network and NCI’s Frederick National Lab award two fellowships

Caris Life Sciences establishes Caris Centers of Excellence for Precision Medicine Network

City of Hope and Trovagene Inc. enter into clinical collaboration

WuXi PharmaTech acquires NextCODE Health

Medical University of South Carolina location upgrades imaging systems

Royal Phillips partners with Indica Labs Inc.

Picador acquires world publishing rights to the debut novel by Paul Goldberg, editor and publisher of The Cancer Letter

Drugs & Targets

CHMP Grants Positive Opinion To Jakavi in Polycythemia Vera

Palmetto GBA publishes CMS coverage policy for Decipher prostate cancer classifier

Ventana Medical Systems submits ALK assay for FDA premarket approval

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login